Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_268cfb293227 in signals
id
sig_268cfb293227
Primary key.
TEXT
event_id
21828
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt","as_of":"2026-04-11T03:10:51.104915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt","company":"TransMedics Group, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt","article_chars":3324,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_cf4087ac943f1f1c","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt","content_type":"text/plain","enriched_at":"2026-04-11T06:09:39.907867+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt","source_event_id":"evt_d4f3c42d30b2","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"1c20041074fe6a6b","kind":"sec_filing","published_at":"20260410","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-10","2026-04-11","May 19, 2026","May 20, 2026","May 6, 2026","December 31, 2026"],"entities":[{"asset_class":"equity","name":"TransMedics Group, Inc.","relevance":"high","symbol":"TMDX","type":"issuer"}],"event_type":"listing","information_gaps":["What changed versus a prior known state is not provided in the signal text (no prior filing comparison content included).","The filing\u2019s full proxy statement details (beyond the overview items listed) are not included in the provided text.","No explicit financial guidance or financial implications are stated in the provided excerpt beyond governance/shareholder vote items."],"key_facts":["Form type: DEFA14A (Schedule 14A proxy statement).","Filed by: TransMedics Group, Inc. (registrant).","Annual meeting: shareholder meeting to be held May 20, 2026.","Meeting time: 8:00 A.M. Eastern Time (virtual meeting noted).","Vote deadline referenced: May 19, 2026, 11:59 PM ET.","Proposal 1: Election of directors (nominees listed as Waleed H. Hassanein, James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, David Weill, M.D.).","Proposal 2: Non-binding advisory approval of compensation paid to named executive officers.","Proposal 3: Amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares by 2,750,000 shares and make other changes (as set forth in the proxy statement).","Proposal 4: Ratify appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026."],"numeric_claims":[{"label":"shares to increase under 2019 Stock Incentive Plan","value":"2,750,000"}],"primary_claim":"TransMedics Group, Inc. filed Form DEFA14A for its 2026 annual meeting proxy materials, including proposals for director elections, an advisory compensation vote, a stock incentive plan amendment, and auditor ratification.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"TransMedics Group, Inc. filed a Schedule 14A proxy statement (DEFA14A) providing notice of its 2026 annual meeting and summarizing shareholder proposals. The filing includes director election items, an advisory vote on executive compensation, an amendment to the 2019 Stock Incentive Plan, and ratification of the independent auditor.","topics":["SEC filing","proxy statement","annual meeting","shareholder proposals","corporate governance","executive compensation","stock incentive plan","independent auditor"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 TransMedics Group, Inc. \u00b7 Filed 20260410","ticker":"TMDX","tickers":["TMDX"],"title":"TMDX filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-150360.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_d4f3c42d30b2"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:2c7c3187068b56f5
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-11T03:10:51.104915+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel